应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RA Brookfield Real Assets Income Fund Inc.
休市中 11-15 16:00:00 EST
13.12
-0.03
-0.23%
盘后
13.08
-0.04
-0.30%
19:28 EST
最高
13.18
最低
13.01
成交量
34.26万
今开
13.15
昨收
13.15
日振幅
1.26%
总市值
7.25亿
流通市值
7.25亿
总股本
5,528万
成交额
448.07万
换手率
0.62%
流通股本
5,528万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Anaptysbio, Inc.盘中异动 快速下跌5.11%报19.14美元
市场透视 · 11-15 23:53
Anaptysbio, Inc.盘中异动 快速下跌5.11%报19.14美元
Igm Biosciences, Inc.盘中异动 早盘快速跳水5.94%
市场透视 · 11-15 22:40
Igm Biosciences, Inc.盘中异动 早盘快速跳水5.94%
Igm Biosciences, Inc.盘中异动 早盘股价大跌5.74%报10.51美元
市场透视 · 11-14 23:08
Igm Biosciences, Inc.盘中异动 早盘股价大跌5.74%报10.51美元
Igm Biosciences, Inc.盘中异动 急速拉升5.91%
市场透视 · 11-13
Igm Biosciences, Inc.盘中异动 急速拉升5.91%
Anaptysbio, Inc.盘中异动 下午盘股价大跌5.13%报21.25美元
市场透视 · 11-13
Anaptysbio, Inc.盘中异动 下午盘股价大跌5.13%报21.25美元
Igm Biosciences, Inc.盘中异动 股价大涨5.20%报13.55美元
市场透视 · 11-12
Igm Biosciences, Inc.盘中异动 股价大涨5.20%报13.55美元
Anaptysbio, Inc.盘中异动 早盘急速拉升5.40%报22.46美元
市场透视 · 11-11
Anaptysbio, Inc.盘中异动 早盘急速拉升5.40%报22.46美元
Igm Biosciences, Inc.盘中异动 大幅上涨5.30%报13.72美元
市场透视 · 11-11
Igm Biosciences, Inc.盘中异动 大幅上涨5.30%报13.72美元
Igm Biosciences, Inc.盘中异动 早盘股价大涨5.28%
市场透视 · 11-07
Igm Biosciences, Inc.盘中异动 早盘股价大涨5.28%
Igm Biosciences, Inc.盘中异动 早盘股价大跌5.45%报14.97美元
市场透视 · 11-06
Igm Biosciences, Inc.盘中异动 早盘股价大跌5.45%报14.97美元
Anaptysbio, Inc.盘中异动 股价大涨9.26%
市场透视 · 11-06
Anaptysbio, Inc.盘中异动 股价大涨9.26%
Igm Biosciences, Inc.盘中异动 快速跳水5.18%报15.38美元
市场透视 · 11-04
Igm Biosciences, Inc.盘中异动 快速跳水5.18%报15.38美元
Anaptysbio, Inc.盘中异动 股价大跌5.26%
市场透视 · 11-04
Anaptysbio, Inc.盘中异动 股价大跌5.26%
Igm Biosciences, Inc.盘中异动 下午盘快速下挫5.02%
市场透视 · 11-02
Igm Biosciences, Inc.盘中异动 下午盘快速下挫5.02%
Anaptysbio, Inc.盘中异动 早盘急速跳水5.14%报21.04美元
市场透视 · 10-31
Anaptysbio, Inc.盘中异动 早盘急速跳水5.14%报21.04美元
标普:确认中银人寿“A”长期本币财务实力评级和发行人信用评级,展望“稳定”
久其财经 · 10-31
标普:确认中银人寿“A”长期本币财务实力评级和发行人信用评级,展望“稳定”
Anaptysbio, Inc.盘中异动 早盘急速下跌25.19%报23.04美元
市场透视 · 10-30
Anaptysbio, Inc.盘中异动 早盘急速下跌25.19%报23.04美元
Anaptysbio, Inc.盘中异动 股价大跌5.84%
市场透视 · 10-28
Anaptysbio, Inc.盘中异动 股价大跌5.84%
Igm Biosciences, Inc.盘中异动 股价大涨6.24%
市场透视 · 10-28
Igm Biosciences, Inc.盘中异动 股价大涨6.24%
苏州又杀出超级IPO:暴涨94.26% 市占率超4.2%
铅笔道 · 10-25
苏州又杀出超级IPO:暴涨94.26% 市占率超4.2%
暂无数据
公司概况
公司名称:
Brookfield Real Assets Income Fund Inc.
所属市场:
NYSE
上市日期:
--
主营业务:
Brookfield Real Assets Income Fund Inc.于2015年10月6日在马里兰州注册成立。这是一家多元化的封闭式管理投资公司。该基金的投资目标是寻求高总回报,主要是通过高当前收入,其次是通过资本增长。
发行价格:
--
{"stockData":{"symbol":"RA","market":"US","secType":"STK","nameCN":"Brookfield Real Assets Income Fund Inc.","latestPrice":13.12,"timestamp":1731704400000,"preClose":13.15,"halted":0,"volume":342607,"hourTrading":{"tag":"盘后","latestPrice":13.08,"preClose":13.12,"latestTime":"19:28 EST","volume":2219,"amount":29025.43,"timestamp":1731716919593},"delay":0,"floatShares":55280700,"shares":55280700,"eps":-1.61933,"marketStatus":"休市中","marketStatusCode":7,"change":-0.03,"latestTime":"11-15 16:00:00 EST","open":13.15,"high":13.18,"low":13.013735,"amount":4480667.792692,"amplitude":0.012644,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.61933,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"adjPreClose":13.15,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":13.15,"preClose":13.15,"latestTime":"08:11 EST","volume":7,"amount":92.019998,"timestamp":1731676305053},"postHourTrading":{"tag":"盘后","latestPrice":13.08,"preClose":13.12,"latestTime":"19:28 EST","volume":2219,"amount":29025.43,"timestamp":1731716919593},"volumeRatio":1.3294926951009873},"requestUrl":"/m/hq/s/RA/tweets","defaultTab":"tweets","newsList":[{"id":"2483530975","title":"Anaptysbio, Inc.盘中异动 快速下跌5.11%报19.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483530975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483530975?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:53","pubTimestamp":1731685980,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时53分,Anaptysbio, Inc.股票出现异动,股价急速下跌5.11%。截至发稿,该股报19.14美元/股,成交量6.1232万股,换手率0.20%,振幅6.35%。Anaptysbio, Inc.股票所在的生物技术行业中,整体跌幅为3.36%。Anaptysbio, Inc.公司简介:AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235301a23b84c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115235301a23b84c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2483837780","title":"Igm Biosciences, Inc.盘中异动 早盘快速跳水5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483837780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483837780?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:40","pubTimestamp":1731681611,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时40分,Igm Biosciences, Inc.股票出现异动,股价大幅跳水5.94%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为1.89%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224011971a6d73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115224011971a6d73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLE","BK4077","BK4505","RA","IGMS"],"gpt_icon":0},{"id":"2483847807","title":"Igm Biosciences, Inc.盘中异动 早盘股价大跌5.74%报10.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483847807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483847807?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:08","pubTimestamp":1731596882,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时08分,Igm Biosciences, Inc.股票出现波动,股价快速跳水5.74%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.75%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、奥麦罗制药涨幅较大,Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为2351.79%、49.16%、34.67%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Abpro Holdings, Inc,振幅分别为75.00%、67.21%、52.95%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114230802971a695f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114230802971a695f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","IGMS","BK4077","SLE","PULM","BK4007","BK4139","BK4505"],"gpt_icon":0},{"id":"2483824118","title":"Igm Biosciences, Inc.盘中异动 急速拉升5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483824118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483824118?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:48","pubTimestamp":1731509286,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时48分,Igm Biosciences, Inc.股票出现波动,股价大幅拉升5.91%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Lexeo Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃,换手率分别为346.25%、204.72%、90.84%,振幅较大的相关个股有Lexeo Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Immunoprecise Antibodies Ltd.,振幅分别为44.21%、36.31%、26.81%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224806a2345ce0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224806a2345ce0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","SLE","IGMS","BK4139","RA","BK4077"],"gpt_icon":0},{"id":"2483545059","title":"Anaptysbio, Inc.盘中异动 下午盘股价大跌5.13%报21.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483545059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483545059?lang=zh_cn&edition=full","pubTime":"2024-11-13 04:19","pubTimestamp":1731442772,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时19分,Anaptysbio, Inc.股票出现波动,股价急速下跌5.13%。截至发稿,该股报21.25美元/股,成交量30.1503万股,换手率0.99%,振幅6.54%。Anaptysbio, Inc.股票所在的生物技术行业中,整体跌幅为1.16%。Anaptysbio, Inc.公司简介:AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304193298e422b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111304193298e422b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2482085750","title":"Igm Biosciences, Inc.盘中异动 股价大涨5.20%报13.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085750?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:40","pubTimestamp":1731422426,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时40分,Igm Biosciences, Inc.股票出现异动,股价大幅拉升5.20%。截至发稿,该股报13.55美元/股,成交量5977股,换手率0.01%,振幅2.10%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224026971a6036&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224026971a6036&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","RA","SLE","BK4077","IGMS"],"gpt_icon":0},{"id":"2482735889","title":"Anaptysbio, Inc.盘中异动 早盘急速拉升5.40%报22.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482735889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482735889?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:53","pubTimestamp":1731336838,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时53分,Anaptysbio, Inc.股票出现异动,股价大幅上涨5.40%。截至发稿,该股报22.46美元/股,成交量3.4123万股,换手率0.11%,振幅4.36%。Anaptysbio, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。其相关个股中,Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc.涨幅较大,Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为448.91%、234.02%、104.73%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Revelation Biosciences, Inc.,振幅分别为76.29%、31.82%、28.01%。Anaptysbio, Inc.公司简介:AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225358971a5ba7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225358971a5ba7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2482900738","title":"Igm Biosciences, Inc.盘中异动 大幅上涨5.30%报13.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482900738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482900738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:36","pubTimestamp":1731335788,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时36分,Igm Biosciences, Inc.股票出现波动,股价急速拉升5.30%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Revelation Biosciences, Inc.涨幅较大,Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为417.11%、151.09%、75.74%,振幅较大的相关个股有天演药业、Windtree Therapeutics, Inc.、Cingulate Inc.,振幅分别为109.34%、109.04%、107.06%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223628971a5b2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223628971a5b2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","SLE","RA","IGMS","BK4077","BK4139"],"gpt_icon":0},{"id":"2481798187","title":"Igm Biosciences, Inc.盘中异动 早盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481798187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481798187?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:35","pubTimestamp":1730993702,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时35分,Igm Biosciences, Inc.股票出现异动,股价快速拉升5.28%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723350298e413c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723350298e413c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4077","RA","IGMS","BK4139","SLE","BK4505"],"gpt_icon":0},{"id":"2481985392","title":"Igm Biosciences, Inc.盘中异动 早盘股价大跌5.45%报14.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985392?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:47","pubTimestamp":1730904473,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时47分,Igm Biosciences, Inc.股票出现波动,股价急速下挫5.45%。截至发稿,该股报14.97美元/股,成交量2.6859万股,换手率0.05%,振幅6.63%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.93%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224754971a4cbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224754971a4cbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IGMS","BK4139","SLE","RA","BK4077","BK4505"],"gpt_icon":0},{"id":"2481064986","title":"Anaptysbio, Inc.盘中异动 股价大涨9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481064986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481064986?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:35","pubTimestamp":1730903707,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时35分,Anaptysbio, Inc.股票出现波动,股价快速上涨9.26%。截至发稿,该股报21.72美元/股,成交量2.3993万股,换手率0.08%,振幅6.39%。Anaptysbio, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃,换手率分别为1070.77%、106.67%、55.19%,振幅较大的相关个股有Lakeshore Biopharma Co., Ltd、Inmed Pharmaceuticals Inc.、Immunitybio, Inc.,振幅分别为107.44%、106.04%、105.49%。Anaptysbio, Inc.公司简介:AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622350795bddc39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622350795bddc39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2480392581","title":"Igm Biosciences, Inc.盘中异动 快速跳水5.18%报15.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480392581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480392581?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:41","pubTimestamp":1730731281,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时41分,Igm Biosciences, Inc.股票出现波动,股价快速跳水5.18%。截至发稿,该股报15.38美元/股,成交量9270股,换手率0.02%,振幅4.78%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.28%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104224121ab9ec2d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104224121ab9ec2d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IGMS","BK4505","BK4077","BK4139","SLE","RA"],"gpt_icon":0},{"id":"2480589012","title":"Anaptysbio, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480589012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480589012?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:35","pubTimestamp":1730730939,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时35分,Anaptysbio, Inc.股票出现波动,股价急速跳水5.26%。截至发稿,该股报20.54美元/股,成交量1.3423万股,换手率0.04%,振幅4.11%。Anaptysbio, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大,Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃,换手率分别为236.79%、140.96%、45.87%,振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 ,振幅分别为29.83%、22.67%、16.12%。Anaptysbio, Inc.公司简介:AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223539971a4276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223539971a4276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2480302978","title":"Igm Biosciences, Inc.盘中异动 下午盘快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480302978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480302978?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:45","pubTimestamp":1730483106,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时45分,Igm Biosciences, Inc.股票出现异动,股价大幅跳水5.02%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102014506ab93fb8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102014506ab93fb8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLE","BK4077","BK4505","RA","IGMS"],"gpt_icon":0},{"id":"2479080970","title":"Anaptysbio, Inc.盘中异动 早盘急速跳水5.14%报21.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080970?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:34","pubTimestamp":1730381669,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时34分,Anaptysbio, Inc.股票出现异动,股价急速跳水5.14%。截至发稿,该股报21.04美元/股,成交量1.4213万股,换手率0.05%,振幅6.33%。Anaptysbio, Inc.股票所在的生物技术行业中,整体跌幅为1.87%。其相关个股中,Aerovate Therapeutics, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Engene Holdings Inc C/Wts 31/10/2028 Cl A涨幅较大,Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃,换手率分别为196.95%、190.01%、146.40%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Equillium, Inc.、Evogene Ltd.,振幅分别为21.98%、14.49%、14.16%。Anaptysbio, Inc.公司简介:AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213429971a3870&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213429971a3870&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2479773074","title":"标普:确认中银人寿“A”长期本币财务实力评级和发行人信用评级,展望“稳定”","url":"https://stock-news.laohu8.com/highlight/detail?id=2479773074","media":"久其财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479773074?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:50","pubTimestamp":1730361028,"startTime":"0","endTime":"0","summary":"久期财经讯,10月31日,标普确认中银集团人寿保险有限公司(BOC Group Life Assurance Company. Limited,简称“中银人寿”)“A”长期本币财务实力评级和发行人信用评级。标普认为,在未来两年内不太可能进行上调。评级确认反映了标普对中银人寿作为中银香港下属子公司的高度战略性子公司的地位的评估。标普在对中银人寿的评级中考虑了来自该集团的支持,该评级比标普对子集团信用状况的评估低一个子级。标普预计中银人寿的增长趋势将在未来两年持续下去。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.97caijing.com/outarticle/list_v3.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSM","RA"],"gpt_icon":0},{"id":"2479783196","title":"Anaptysbio, Inc.盘中异动 早盘急速下跌25.19%报23.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479783196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479783196?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:32","pubTimestamp":1730295147,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时32分,Anaptysbio, Inc.股票出现波动,股价大幅跳水25.19%。截至发稿,该股报23.04美元/股,成交量32.1528万股,换手率1.06%,振幅2.41%。Anaptysbio, Inc.股票所在的生物技术行业中,整体跌幅为0.31%。其相关个股中,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.涨幅较大,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1795.46%、99.39%、17.05%,振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Cormedix Inc.,振幅分别为27.09%、11.49%、11.41%。Anaptysbio, Inc.公司简介:AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021322895bd8e26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"69b555e67b9b57f18da6272607047169","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021322895bd8e26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2478486145","title":"Anaptysbio, Inc.盘中异动 股价大跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486145?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:35","pubTimestamp":1730122525,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时35分,Anaptysbio, Inc.股票出现异动,股价快速跳水5.84%。截至发稿,该股报30.16美元/股,成交量8.8553万股,换手率0.29%,振幅6.68%。Anaptysbio, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.、Revance Therapeutics, Inc.涨幅较大,Tc Biopharm Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃,换手率分别为546.87%、48.35%、36.95%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Calidi Biotherapeutics, Inc.、Monopar Therapeutics Inc.,振幅分别为34.60%、18.35%、16.85%。Anaptysbio, Inc.公司简介:AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821352598e3ecfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821352598e3ecfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2478758486","title":"Igm Biosciences, Inc.盘中异动 股价大涨6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478758486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478758486?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:34","pubTimestamp":1730122475,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时34分,Igm Biosciences, Inc.股票出现波动,股价快速上涨6.24%。Igm Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Igm Biosciences, Inc.公司简介:IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司,用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213435971a2a24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213435971a2a24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IGMS","BK4505","BK4077","BK4139","SLE","RA"],"gpt_icon":0},{"id":"2478024776","title":"苏州又杀出超级IPO:暴涨94.26% 市占率超4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478024776","media":"铅笔道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478024776?lang=zh_cn&edition=full","pubTime":"2024-10-25 14:32","pubTimestamp":1729837953,"startTime":"0","endTime":"0","summary":"铅笔道作者 | 海有梦近日,江苏苏州又杀出个超级IPO:胜科纳米,向科创板递交了申请,冲击IPO。它的业务是:半导体第三方检测分析实验室。一个常见的场景,就是帮芯片看病,分析哪里坏了,原因是啥——被称为“芯片全科医院”。这是一家怎样的神奇公司?01胜科纳米于2012年在苏州成立,由李晓旻先生创办。他本科毕业于北京...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OxSXnJpkWehcj7FJKt8tPzCj8302LWfuIE55ebjKNSz7gAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OxSXnJpkWehcj7FJKt8tPzCj8302LWfuIE55ebjKNSz7gAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241025A059V300","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241025A059V300","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU0056508442.USD","LU0053666078.USD","LU0234572021.USD","BK4527","LU0170899867.USD","IE00B1XK9C88.USD","LU0006306889.USD","MA","BK4539","LU0107464264.USD","LU0106261372.USD","LU0640476718.USD","BK4533","LU0096362180.USD","IE00BFSS8Q28.SGD","IE00B4JS1V06.HKD","LU0061474960.USD","LU0238689110.USD","LU0256863811.USD","IE00B775H168.HKD","IE00BN29S564.USD","LU0390134368.USD","IE00B7KXQ091.USD","RA","LU0127658192.USD","LU0316494557.USD","IE00BQXX3F31.USD","BK4566","LU0011850046.USD","LU0109392836.USD","BK4535","LU0494093205.USD","BK4588","IE00BFSS7M15.SGD","LU0289941410.SGD","LU0094547139.USD","LU0198837287.USD","LU0345769128.USD","BK4559","LU0353189680.USD","BK4534","BK4581","IE00BHPRN162.USD","FA","LU0353189763.USD","IE00B5TLWC47.USD","LU0276348264.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","BK4106"],"gpt_icon":0}],"profile":{"websiteUrl":"http://publicsecurities.brookfield.com","stockEarnings":[{"period":"1week","weight":-0.0317},{"period":"1month","weight":-0.0281},{"period":"3month","weight":0.0008},{"period":"6month","weight":0.0323},{"period":"1year","weight":0.0564},{"period":"ytd","weight":0.0242}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Brookfield Real Assets Income Fund Inc.于2015年10月6日在马里兰州注册成立。这是一家多元化的封闭式管理投资公司。该基金的投资目标是寻求高总回报,主要是通过高当前收入,其次是通过资本增长。","yearOnYearQuotes":[{"month":1,"riseRate":0.875,"avgChangeRate":0.036584},{"month":2,"riseRate":0.5,"avgChangeRate":-0.003208},{"month":3,"riseRate":0.375,"avgChangeRate":-0.042379},{"month":4,"riseRate":0.75,"avgChangeRate":0.035444},{"month":5,"riseRate":0.375,"avgChangeRate":-0.012785},{"month":6,"riseRate":0.5,"avgChangeRate":-0.003373},{"month":7,"riseRate":1,"avgChangeRate":0.028604},{"month":8,"riseRate":0.375,"avgChangeRate":-0.030588},{"month":9,"riseRate":0.25,"avgChangeRate":-0.026858},{"month":10,"riseRate":0.375,"avgChangeRate":-0.013464},{"month":11,"riseRate":0.375,"avgChangeRate":0.007779},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.024652}],"exchange":"NYSE","name":"Brookfield Real Assets Income Fund Inc.","nameEN":"Brookfield Real Assets Income Fund Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Brookfield Real Assets Income Fund Inc.(RA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Brookfield Real Assets Income Fund Inc.(RA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Brookfield Real Assets Income Fund Inc.,RA,Brookfield Real Assets Income Fund Inc.股票,Brookfield Real Assets Income Fund Inc.股票老虎,Brookfield Real Assets Income Fund Inc.股票老虎国际,Brookfield Real Assets Income Fund Inc.行情,Brookfield Real Assets Income Fund Inc.股票行情,Brookfield Real Assets Income Fund Inc.股价,Brookfield Real Assets Income Fund Inc.股市,Brookfield Real Assets Income Fund Inc.股票价格,Brookfield Real Assets Income Fund Inc.股票交易,Brookfield Real Assets Income Fund Inc.股票购买,Brookfield Real Assets Income Fund Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Brookfield Real Assets Income Fund Inc.(RA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Brookfield Real Assets Income Fund Inc.(RA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}